BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Business

  Genentech Inks $330 Million Tie-Up With Startup to Discover “Breathrough” Therapies

  June 27, 2013

   · 

  4 min read
• Deals

  Merck & Co., Inc. Sells 11 Drugs and an API Plant to Aspen Pharmacare Holdings for $1 Billion

  June 27, 2013

   · 

  4 min read
• Drug Development

  GlaxoSmithKline Muscular Dystrophy Drug Gets “Breakthrough” Status

  June 27, 2013

   · 

  1 min read
• BioMidwest

  Eli Lilly and Company Hopes to End Novo Nordisk A/S’s Stranglehold on the GLP-1 Market

  June 27, 2013

   · 

  1 min read
• Policy

  Sprout Pharmaceuticals Tries Again With “Pink Viagra”

  June 27, 2013

   · 

  1 min read
• Deals

  Amgen, Pfizer Inc. Duke it Out for Takeover of BioCad, Deal May Top $1 Billion

  June 27, 2013

   · 

  1 min read
• Pharm Country

  Merck Serono Creates New Immuno-Oncology Platform

  June 27, 2013

   · 

  1 min read
• Business

  ResMed Inc. Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year-End 2013 Results

  June 27, 2013

   · 

  1 min read
• The Royal Liverpool University Hospital Becomes First National Health Service Facility in England to Achieve the Highest Level of Accreditation for “First in Human” Clinical Trials

  June 27, 2013

   · 

  4 min read
• Daval International Limited Release: Detailed Molecular Analysis of Aimspro® to be Presented at the 16th Conference in Genomics and Proteomics of Human Pathogens 27-28 June

  June 27, 2013

   · 

  3 min read